Table 7. Top 10 cancer incidence rates in cancer registration areas in 2009.
Rank | Both |
Male |
Female |
|||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Site | Incidence rate (1/105) | % | ASIRC* (1/105) |
Site | Incidence rate (1/105) | % | ASIRC* (1/105) |
Site | Incidence rate (1/105) | % | ASIRC* (1/105) | |||
1 | Lung (C33-34) | 53.57 | 18.74 | 25.34 | Lung (C33-34) | 70.40 | 22.14 | 34.75 | Breast (C50) | 42.55 | 16.81 | 23.16 | ||
2 | Stomach (C16) | 36.21 | 12.67 | 17.85 | Stomach (C16) | 49.61 | 15.60 | 25.37 | Lung (C33-34) | 36.34 | 14.36 | 16.41 | ||
3 | Colon, rectum (C18-21) | 29.44 | 10.30 | 14.21 | Liver (C22) | 41.99 | 13.21 | 22.49 | Colon, rectum (C18-21) |
26.42 | 10.44 | 12.29 | ||
4 | Liver (C22) | 28.71 | 10.04 | 14.78 | Colon, rectum (C18-21) | 32.38 | 10.18 | 16.23 | Stomach (C16) | 22.50 | 8.89 | 10.62 | ||
5 | Esophagus (C15) | 22.14 | 7.74 | 10.88 | Esophagus (C15) | 30.44 | 9.57 | 15.62 | Liver (C22) | 15.11 | 5.97 | 7.11 | ||
6 | Breast (C50) | 21.21 | 7.42 | 11.64 | Prostate (C61) | 9.92 | 3.12 | 4.34 | Esophagus (C15) | 13.64 | 5.39 | 6.27 | ||
7 | Pancreas (C25) | 7.28 | 2.55 | 3.35 | Bladder (C67) | 9.78 | 3.08 | 4.70 | Cervix (C53) | 12.96 | 5.12 | 7.42 | ||
8 | Lymphoma (C81-85, 88, 90, 96) | 6.68 | 2.34 | 3.75 | Pancreas (C25) | 8.24 | 2.59 | 4.01 | Thyroid (C73) | 10.09 | 3.99 | 6.50 | ||
9 | Bladder (C67) | 6.61 | 2.31 | 3.03 | Lymphoma | 7.71 | 2.42 | 4.46 | Uterus (C54-55) | 8.77 | 3.46 | 4.69 | ||
10 | Thyroid (C73) | 6.56 | 2.29 | 4.21 | Kidney (C64-66, 68) |
7.07 | 2.22 | 3.82 | Ovary (C56) | 7.95 | 3.14 | 4.54 | ||
Top 10 | 218.40 | 76.39 | 109.05 | Top 10 | 267.55 | 84.14 | 135.81 | Top 10 | 196.32 | 77.57 | 99.01 |
*Age-standardized incidence rate (China population)